Tower Cold Chain, a leading pharmaceutical temperature-controlled logistics expert based in Theale, Reading, has secured a prestigious win at the highly acclaimed Insider’s Made in Southeast Awards 2023. The company proudly took home the Manufacturing Innovation Award, a testament to its contribution to the delivery of lifesaving medicines.
Tower’s achievement is a recognition of its pivotal role in ensuring the secure transportation of critical pharmaceuticals. Specifically, the company played a pivotal role in the efficient and reliable delivery of COVID-19 vaccines, showcasing its commitment to global health initiatives.
Notably, Tower Cold Chain has consistently demonstrated its dedication to innovation with the introduction of cutting-edge solutions designed to meet the evolving needs of the pharmaceutical industry. During the pandemic, the company launched the KTM42D, an advanced solution tailored for ultra-cold temperature critical pharmaceuticals. This innovation has significantly contributed to the success of distributing and maintaining the integrity of temperature-sensitive vaccines.
In addition, Tower Cold Chain introduced the KTEvolution, a revolutionary lightweight solution that can be handled manually. This versatile solution is ideal for smaller shipments, including direct-to-patient deliveries, clinical trials, and last-mile distribution. The KTEvolution not only enhances the efficiency of pharmaceutical logistics but also addresses the specific challenges associated with transporting smaller quantities of critical medications.
“The Manufacturing Innovation Award highlights Tower Cold Chain’s pivotal role in driving innovations in healthcare,” says Niall Balfour, CEO of Tower Cold Chain. “As an organisation founded in the South East, we take great pride in our significant local contributions that resonate globally, in the delivery of lifesaving pharmaceuticals.”
